Balansky, J.; Pfarr, K.; Szekat, C.; Kehraus, S.; Aden, T.; Grosse, M.; Jansen, R.; Hesterkamp, T.; Schiefer, A.; König, G.M.;
et al. The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus. Antibiotics 2022, 11, 920.
https://doi.org/10.3390/antibiotics11070920
AMA Style
Balansky J, Pfarr K, Szekat C, Kehraus S, Aden T, Grosse M, Jansen R, Hesterkamp T, Schiefer A, König GM,
et al. The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus. Antibiotics. 2022; 11(7):920.
https://doi.org/10.3390/antibiotics11070920
Chicago/Turabian Style
Balansky, Jan, Kenneth Pfarr, Christiane Szekat, Stefan Kehraus, Tilman Aden, Miriam Grosse, Rolf Jansen, Thomas Hesterkamp, Andrea Schiefer, Gabriele M. König,
and et al. 2022. "The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus" Antibiotics 11, no. 7: 920.
https://doi.org/10.3390/antibiotics11070920
APA Style
Balansky, J., Pfarr, K., Szekat, C., Kehraus, S., Aden, T., Grosse, M., Jansen, R., Hesterkamp, T., Schiefer, A., König, G. M., Stadler, M., Hoerauf, A., & Bierbaum, G.
(2022). The RNA Polymerase Inhibitor Corallopyronin A Has a Lower Frequency of Resistance Than Rifampicin in Staphylococcus aureus. Antibiotics, 11(7), 920.
https://doi.org/10.3390/antibiotics11070920